By Andrew Silver SHANGHAI, Nov 12 (Reuters) – Eli Lilly on Thursday became the first company to have a GLP-1 weight-loss pill approved in China, gaining a leg up on Danish rival Novo Nordisk in the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Fritz rallies past Norrie to reach Stockholm quarter-finals
VIDEO SHOWS: HIGHLIGHTS FROM THE STOCKHOLM OPEN WITH TAYLOR FRITZ BEATING CAMERON NORRIE SHOWS: STOCKHOLM,…
NORDIC COUNTRIES TO WORK ON CONCLUDING A JOINT DEFENCE DEAL, NORWAY MINISTER SAYS
NORDIC COUNTRIES TO WORK ON CONCLUDING A JOINT DEFENCE DEAL, NORWAY MINISTER SAYS (The article…
Setback for Google as EU Court adviser backs $1.7 billion antitrust fine
BRUSSELS, Nov 12 (Reuters) - Google suffered a setback on Thursday as an adviser to…
